foxo4-dri senolytic study FOXO4-DRI: Kill Senescent Cells, Restore Organs (2026) FOXO4-DRI UK | Senolytic Peptide

Hur GH, Han SC, Ryu AR, et al

This regulatory status establishes these peptides strictly as research-use-only materials appropriate exclusively for laboratory investigation in qualified research settings rather than any form of clinical, therapeutic, or diagnostic application

and Brigham Buhler, a compounding pharmacy owner whom Kennedy previously hosted on his podcast

N Engl J Med 2022

Final Thoughts on GHK-Cu vs BPC-157 If you are deciding between GHK-Cu vs BPC-157 , the best choice depends entirely on the research target: Choose GHK-Cu for skin quality, collagen support, fibroblast signaling, scar support, and dermal remodeling

The complexation of copper with GHK does not induce cytotoxicity to primary human cells at research-relevant concentrations